NCT06924580 Early ECG Prediction of Multi-system Disease Cohort Establishment and Follow Up
| NCT ID | NCT06924580 |
| Status | Recruiting |
| Phase | — |
| Sponsor | RenJi Hospital |
| Condition | Public Health |
| Study Type | OBSERVATIONAL |
| Enrollment | 500,000 participants |
| Start Date | 2017-01-18 |
| Primary Completion | 2026-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 500,000 participants in total. It began in 2017-01-18 with a primary completion date of 2026-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This registered multicenter study aims to investigate the diagnostic efficacy of artificial intelligence-enhanced electrocardiography (AI-ECG) in detecting multi-system diseases. The research will utilize prospectively collected data from inpatient, emergency, and outpatient populations to develop ECG-based diagnostic, screening, and predictive models for multi-system diseases.
Eligibility Criteria
Inclusion Criteria: 1. Patients who visited the study hospital. 2. Patients included should have both ECG data and discharge diagnosis codes (ICD-10) for inpatients and emergency patients. Exclusion Criteria: 1\. Patients who declined participation, cases with incomplete or missing clinical data, and pregnant individuals.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06924580 clinical trial?
This trial is open to participants of all sexes, studying Public Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06924580 currently recruiting?
Yes, NCT06924580 is actively recruiting participants. Contact the research team at pujun310@hotmail.com for enrollment information.
Where is the NCT06924580 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06924580 clinical trial?
NCT06924580 is sponsored by RenJi Hospital. The trial plans to enroll 500,000 participants.